
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
Dandan Tian, Yanhong Sun, Jianming Zhou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 191
Dandan Tian, Yanhong Sun, Jianming Zhou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 191
Showing 1-25 of 191 citing articles:
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
Pengcheng Han, Linjie Li, Sheng Liu, et al.
Cell (2022) Vol. 185, Iss. 4, pp. 630-640.e10
Open Access | Times Cited: 449
Pengcheng Han, Linjie Li, Sheng Liu, et al.
Cell (2022) Vol. 185, Iss. 4, pp. 630-640.e10
Open Access | Times Cited: 449
The emergence and epidemic characteristics of the highly mutated SARS‐CoV‐2 Omicron variant
Dandan Tian, Yanhong Sun, Huihong Xu, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 6, pp. 2376-2383
Open Access | Times Cited: 428
Dandan Tian, Yanhong Sun, Huihong Xu, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 6, pp. 2376-2383
Open Access | Times Cited: 428
SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies
MacGregor Cox, Thomas P. Peacock, William T. Harvey, et al.
Nature Reviews Microbiology (2022) Vol. 21, Iss. 2, pp. 112-124
Open Access | Times Cited: 261
MacGregor Cox, Thomas P. Peacock, William T. Harvey, et al.
Nature Reviews Microbiology (2022) Vol. 21, Iss. 2, pp. 112-124
Open Access | Times Cited: 261
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 166
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 166
The puzzling mutational landscape of the SARS‐2‐variant Omicron
Jacques Fantini, Nouara Yahi, Philippe Colson, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 2019-2025
Open Access | Times Cited: 77
Jacques Fantini, Nouara Yahi, Philippe Colson, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 2019-2025
Open Access | Times Cited: 77
Twin combination of Omicron and Delta variants triggering a tsunami wave of ever high surges in COVID‐19 cases: A challenging global threat with a special focus on the Indian subcontinent
Ranjan K. Mohapatra, Ruchi Tiwari, Ashish K. Sarangi, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1761-1765
Open Access | Times Cited: 75
Ranjan K. Mohapatra, Ruchi Tiwari, Ashish K. Sarangi, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1761-1765
Open Access | Times Cited: 75
The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
Vivek P. Chavda, Rajashri Bezbaruah, Kangkan Deka, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1926-1926
Open Access | Times Cited: 71
Vivek P. Chavda, Rajashri Bezbaruah, Kangkan Deka, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1926-1926
Open Access | Times Cited: 71
mRNA Vaccines Against SARS‐CoV‐2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable Lipids
Kepan Chen, Na Fan, Hai Huang, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 39
Open Access | Times Cited: 67
Kepan Chen, Na Fan, Hai Huang, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 39
Open Access | Times Cited: 67
Molecular insights into the adaptive evolution of SARS-CoV-2 spike protein
Zhuocheng Yao, Lin Zhang, Yuange Duan, et al.
Journal of Infection (2024) Vol. 88, Iss. 3, pp. 106121-106121
Open Access | Times Cited: 14
Zhuocheng Yao, Lin Zhang, Yuange Duan, et al.
Journal of Infection (2024) Vol. 88, Iss. 3, pp. 106121-106121
Open Access | Times Cited: 14
Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1, and JN.1 six months after the BNT162b2 bivalent booster
Julien Favresse, Constant Gillot, Julien Cabo, et al.
International Journal of Infectious Diseases (2024) Vol. 143, pp. 107028-107028
Open Access | Times Cited: 14
Julien Favresse, Constant Gillot, Julien Cabo, et al.
International Journal of Infectious Diseases (2024) Vol. 143, pp. 107028-107028
Open Access | Times Cited: 14
Omicron variant: Current insights and future directions
Rashmi Rana, Ravi Kant, Rohit Singh Huirem, et al.
Microbiological Research (2022) Vol. 265, pp. 127204-127204
Open Access | Times Cited: 66
Rashmi Rana, Ravi Kant, Rohit Singh Huirem, et al.
Microbiological Research (2022) Vol. 265, pp. 127204-127204
Open Access | Times Cited: 66
Mutations in SARS-CoV-2 structural proteins: a global analysis
Mohammad Abavisani, Karim Rahimian, Bahar Mahdavi, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 57
Mohammad Abavisani, Karim Rahimian, Bahar Mahdavi, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 57
Neutralizing Activities Against the Omicron Variant After a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination
Suvichada Assawakosri, Sitthichai Kanokudom, Nungruthai Suntronwong, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 8, pp. 1372-1381
Open Access | Times Cited: 56
Suvichada Assawakosri, Sitthichai Kanokudom, Nungruthai Suntronwong, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 8, pp. 1372-1381
Open Access | Times Cited: 56
Challenges of SARS-CoV-2 Omicron Variant and appropriate countermeasures
Wenxia Shao, Weiying Zhang, Xiang Fang, et al.
Journal of Microbiology Immunology and Infection (2022) Vol. 55, Iss. 3, pp. 387-394
Open Access | Times Cited: 44
Wenxia Shao, Weiying Zhang, Xiang Fang, et al.
Journal of Microbiology Immunology and Infection (2022) Vol. 55, Iss. 3, pp. 387-394
Open Access | Times Cited: 44
Timeline of changes in spike conformational dynamics in emergent SARS-CoV-2 variants reveal progressive stabilization of trimer stalk with altered NTD dynamics
Sean M. Braet, Theresa SC Buckley, Varun Venkatakrishnan, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 28
Sean M. Braet, Theresa SC Buckley, Varun Venkatakrishnan, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 28
Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies
Niloofar Faraji, Tahereh Zeinali, Farahnaz Joukar, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30208-e30208
Open Access | Times Cited: 11
Niloofar Faraji, Tahereh Zeinali, Farahnaz Joukar, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30208-e30208
Open Access | Times Cited: 11
SARS-CoV-2 spike protein receptor binding domain promotes IL-6 and IL-8 release via ATP/P2Y2 and ERK1/2 signaling pathways in human bronchial epithelia
Rui‐Gang Zhang, Xingjian Liu, Yuling Guo, et al.
Molecular Immunology (2024) Vol. 167, pp. 53-61
Closed Access | Times Cited: 9
Rui‐Gang Zhang, Xingjian Liu, Yuling Guo, et al.
Molecular Immunology (2024) Vol. 167, pp. 53-61
Closed Access | Times Cited: 9
The mRNA vaccine, a swift warhead against a moving infectious disease target
Sheema Mir, Mohammad A. Mir
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 336-348
Open Access | Times Cited: 8
Sheema Mir, Mohammad A. Mir
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 336-348
Open Access | Times Cited: 8
Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity
Ritika Khatri, Gazala Siddqui, Srikanth Sadhu, et al.
Medical Microbiology and Immunology (2022) Vol. 212, Iss. 1, pp. 103-122
Open Access | Times Cited: 35
Ritika Khatri, Gazala Siddqui, Srikanth Sadhu, et al.
Medical Microbiology and Immunology (2022) Vol. 212, Iss. 1, pp. 103-122
Open Access | Times Cited: 35
SARS-CoV-2 pseudovirus enters the host cells through spike protein-CD147 in an Arf6-dependent manner
Yun-Qi Zhou, Ke Wang, Xueyan Wang, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1135-1144
Open Access | Times Cited: 33
Yun-Qi Zhou, Ke Wang, Xueyan Wang, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1135-1144
Open Access | Times Cited: 33
Alveolar macrophages: Achilles’ heel of SARS-CoV-2 infection
Zhenfeng Wang, Shunshun Li, Bo Huang
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 29
Zhenfeng Wang, Shunshun Li, Bo Huang
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 29
SARS-CoV-2 VOCs, Mutational diversity and clinical outcome: Are they modulating drug efficacy by altered binding strength?
Sheeba Saifi, Varsha Ravi, Sparsh Sharma, et al.
Genomics (2022) Vol. 114, Iss. 5, pp. 110466-110466
Open Access | Times Cited: 29
Sheeba Saifi, Varsha Ravi, Sparsh Sharma, et al.
Genomics (2022) Vol. 114, Iss. 5, pp. 110466-110466
Open Access | Times Cited: 29
COVID-19 and the brain: understanding the pathogenesis and consequences of neurological damage
Sumaiya Tasnim Maliha, Rabeya Fatemi, Yusha Araf
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 5
Sumaiya Tasnim Maliha, Rabeya Fatemi, Yusha Araf
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 5
Comparison of ICU Mortality Rates Among Critically Ill COVID-19 Pneumonia Patients Across the First and Second Waves: A Single-Center Retrospective Analysis
Tejas VM, Veena Rm, Mohan ME
Cureus (2025)
Open Access
Tejas VM, Veena Rm, Mohan ME
Cureus (2025)
Open Access
Metabolic syndrome enhances SARS-CoV-2 disease severity and reduces mRNA vaccine efficacy in a mouse model
Elizabeth Geerling, E. Taylor Stone, Danielle Carpenter, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Elizabeth Geerling, E. Taylor Stone, Danielle Carpenter, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access